Yi Zhang1, Qichang Fu1, Yuting Wang2, Jingliang Cheng1, Cuiping Ren1, Sheng Guan3, Chengcheng Zhu4,5. 1. Department of Magnetic Resonance, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 2. Department of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. 3. Department of Interventional neuroradiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 4. Department of Radiology, University of Washington, Seattle, WA, United States. 5. Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Abstract
OBJECTIVE: Intracranial aneurysm wall enhancement (AWE) is independently associated with unstable aneurysms. However, a quantitative analysis of wall enhancement is lacking. This study aims to investigate the relationship between qualitative and quantitative wall enhancement indices (WEIs), traditional risk factors for aneurysms, and clinical ELAPSS/PHASES scores in a large cohort of intracranial saccular aneurysms. MATERIALS AND METHODS: In this cross-sectional study, a total of 174 patients (mean age 60.4 ± 9.5 years; 53% women) with 248 asymptomatic unruptured intracranial aneurysms underwent pre- and post-contrast black-blood magnetic resonance imaging (MRI). The extent of AWE was defined as non-AWE (pattern 0), focal AWE (pattern 1), or circumferential AWE (pattern 2). WEI was calculated using wall signal intensities on pre- and post-contrast images. Predicted 3- and 5-year growth risk and 5-year rupture risk were obtained from ELAPSS and PHASES scores, respectively. Uni- and multivariate analyses were conducted to explore the relationship between AWE characteristics, risk-related factors, and aneurysm instability. RESULTS: Aneurysm size [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.2-1.4; P < 0.001], non-internal carotid artery/middle cerebral artery location (OR, 1.9; 95% CI, 1.0-3.6; P = 0.045), and irregular shape (OR, 2.4; 95% CI, 1.2-4.5; P = 0.009) were independently associated with AWE. For aneurysms with AWE, the estimated 3- and 5-year growth risk (25.3 ± 13.0% and 38.0 ± 17.4%) and the 5-year rupture risk (3.9 ± 5.2%) were 1.9-3.3 times higher than those for aneurysms without AWE (12.8 ± 9.1%, 20.3 ± 13.0%, and 1.2 ± 1.6%, respectively; all P < 0.001). Larger areas and higher WEIs of enhancement positively correlated with aneurysm size (r = 0.43 and 0.38, respectively), 3- and 5-year growth risk, and 5-year rupture risk (r = 0.49 and 0.40, r = 0.49 and 0.40, r = 0.36 and 0.24, respectively; all P < 0.001). In sum, a larger aneurysm size, non-internal carotid artery/middle cerebral artery location, and irregular shape were independently associated with AWE. Larger areas and higher WEIs were associated with an increased risk of aneurysm growth and rupture. These findings suggest that quantitative AWE metrics should be considered in future large-scale longitudinal studies to evaluate their value in aneurysm risk management.
OBJECTIVE: Intracranial aneurysm wall enhancement (AWE) is independently associated with unstable aneurysms. However, a quantitative analysis of wall enhancement is lacking. This study aims to investigate the relationship between qualitative and quantitative wall enhancement indices (WEIs), traditional risk factors for aneurysms, and clinical ELAPSS/PHASES scores in a large cohort of intracranial saccular aneurysms. MATERIALS AND METHODS: In this cross-sectional study, a total of 174 patients (mean age 60.4 ± 9.5 years; 53% women) with 248 asymptomatic unruptured intracranial aneurysms underwent pre- and post-contrast black-blood magnetic resonance imaging (MRI). The extent of AWE was defined as non-AWE (pattern 0), focal AWE (pattern 1), or circumferential AWE (pattern 2). WEI was calculated using wall signal intensities on pre- and post-contrast images. Predicted 3- and 5-year growth risk and 5-year rupture risk were obtained from ELAPSS and PHASES scores, respectively. Uni- and multivariate analyses were conducted to explore the relationship between AWE characteristics, risk-related factors, and aneurysm instability. RESULTS: Aneurysm size [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.2-1.4; P < 0.001], non-internal carotid artery/middle cerebral artery location (OR, 1.9; 95% CI, 1.0-3.6; P = 0.045), and irregular shape (OR, 2.4; 95% CI, 1.2-4.5; P = 0.009) were independently associated with AWE. For aneurysms with AWE, the estimated 3- and 5-year growth risk (25.3 ± 13.0% and 38.0 ± 17.4%) and the 5-year rupture risk (3.9 ± 5.2%) were 1.9-3.3 times higher than those for aneurysms without AWE (12.8 ± 9.1%, 20.3 ± 13.0%, and 1.2 ± 1.6%, respectively; all P < 0.001). Larger areas and higher WEIs of enhancement positively correlated with aneurysm size (r = 0.43 and 0.38, respectively), 3- and 5-year growth risk, and 5-year rupture risk (r = 0.49 and 0.40, r = 0.49 and 0.40, r = 0.36 and 0.24, respectively; all P < 0.001). In sum, a larger aneurysm size, non-internal carotid artery/middle cerebral artery location, and irregular shape were independently associated with AWE. Larger areas and higher WEIs were associated with an increased risk of aneurysm growth and rupture. These findings suggest that quantitative AWE metrics should be considered in future large-scale longitudinal studies to evaluate their value in aneurysm risk management.
Authors: M D I Vergouwen; D Backes; I C van der Schaaf; J Hendrikse; R Kleinloog; A Algra; G J E Rinkel Journal: AJNR Am J Neuroradiol Date: 2019-06-20 Impact factor: 3.825
Authors: Jorge A Roa; Mario Zanaty; Carlos Osorno-Cruz; Daizo Ishii; Girish Bathla; Santiago Ortega-Gutierrez; David M Hasan; Edgar A Samaniego Journal: J Neurosurg Date: 2020-02-07 Impact factor: 5.115
Authors: S Nagahata; M Nagahata; M Obara; R Kondo; N Minagawa; S Sato; S Sato; W Mouri; S Saito; T Kayama Journal: Clin Neuroradiol Date: 2014-10-21 Impact factor: 3.649
Authors: N Larsen; C von der Brelie; D Trick; C H Riedel; T Lindner; J Madjidyar; O Jansen; M Synowitz; C Flüh Journal: AJNR Am J Neuroradiol Date: 2018-07-19 Impact factor: 3.825
Authors: David M Hasan; Kelly B Mahaney; Vincent A Magnotta; David K Kung; Michael T Lawton; Tomoki Hashimoto; H Richard Winn; David Saloner; Alastair Martin; Seymur Gahramanov; Edit Dósa; Edward Neuwelt; William L Young Journal: Arterioscler Thromb Vasc Biol Date: 2012-02-09 Impact factor: 8.311
Authors: Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra Journal: Lancet Neurol Date: 2013-11-27 Impact factor: 44.182
Authors: Charles C Matouk; Daniel M Mandell; Murat Günel; Ketan R Bulsara; Ajay Malhotra; Ryan Hebert; Michele H Johnson; David J Mikulis; Frank J Minja Journal: Neurosurgery Date: 2013-03 Impact factor: 4.654
Authors: Ashrita Raghuram; Alberto Varon; Jorge A Roa; Daizo Ishii; Yongjun Lu; Madhavan L Raghavan; Chaorong Wu; Vincent A Magnotta; David M Hasan; Timothy R Koscik; Edgar A Samaniego Journal: Sci Rep Date: 2021-09-15 Impact factor: 4.379